Richard Paulson - 06 Nov 2024 Form 4 Insider Report for bluebird bio, Inc. (BLUE)

Role: Director
Signature: /s/ Sydney Gaylin, Attorney-in-Fact
Issuer symbol: BLUE
Transactions as of: 06 Nov 2024
Net transactions value: $0
Form type: 4
Filing time: 08 Nov 2024, 16:08:53 UTC
Previous filing: 06 Nov 2024
Next filing: 05 Dec 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BLUE	Common Stock	Award	$0	+24,900	+534%	$0.000000	29,563	06 Nov 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BLUE	Stock Option (right to buy)	Award	$0	+49,850		$0.000000	49,850	06 Nov 2024	Common Stock	49,850	$0.4400	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These restricted stock units for common stock vest 100% on the earlier of November 6, 2025 or the date of the next annual meeting of stockholders.
F2	This option vests 100% on the earlier of November 6, 2025 or the date of the next annual meeting of stockholders.